Saturday, April 19, 2014 Last update: 1:33 PM
Fast Breaking Live News = 100's of Daily Sales Leads

IlluminOss Medical To Present at OneMedForum in San Francisco

Companies mentioned in this article: IlluminOss Medical

SAN FRANCISCO -- (BUSINESS WIRE) -- IlluminOss Medical, a privately held, commercial stage medical device company pioneering the development of minimally invasive, customized orthopedic implants for the stabilization and treatment of bone fractures announced that president and CEO Dirk Kuyper will present at the 2014 OneMedForum in San Francisco on January 13 at 11:45 a.m. PST.

IlluminOss will provide an overview of its Photodynamic Bone Stabilization System (PBSS), a minimally invasive technology that allows for fracture fixation through patient specific intramedullary implants.

Dirk Kuyper will be available for one-on-one meetings during the conference.

Event

      OneMedForum 2014

Date

January 13, 2014

Time

11:45 AM PST

Place

The Stanford Room
The Westin San Francisco Market Street
50 3rd Street, San Francisco
 

About IlluminOss Medical

IlluminOss Medical is a privately-held, commercial stage medical device company focused on designing, developing and marketing orthopedic fracture repair products that leverage its proprietary bone stabilization technology, Photodynamic Bone Stabilization System (PBSS). This minimally invasive technology allows for fracture fixation through patient specific intramedullary implants. The PBSS System utilizes a light-curable polymer, contained within an expandable balloon catheter, to achieve bone stabilization. The revolutionary procedure is made through a small percutaneous surgical approach providing patients and clinicians with a fast, patient-customized, method of orthopedic bone stabilization. The company currently markets its products in international countries under a CE Mark for approved clinical applications through both a direct sales force and distribution networks. Founded in 2007, IlluminOss is headquartered in East Providence, RI, and funded by Foundation Medical Partners, New Leaf Venture Partners, Tekla Capital, Life Sciences Partners, SR One, Longwood Fund, Excel Venture Management, Pappas Ventures, Mieza Capital and Slater Technology. Learn more at www.illuminoss.com.

The IlluminOss products are Investigational Devices; limited by Federal law to Investigational Use and are not approved for sale in the USA.


Copyright © Business Wire 2014
Contact:

For IlluminOss Medical
Dave Connolly, 617-374-8800
dconnolly@lavoiegroup.com
or
Lisa Decenza, 617-374-8800
ldecenza@lavoiegroup.com